Anika Therapeutics Inc (ANIK)
Anika Therapeutics Inc (ANIK) is a biotechnology company specializing in the development and commercialization of innovative products for tissue protection, healing, and repair. It focuses on orthopedics and ophthalmology, offering advanced bioengineered solutions based on hyaluronic acid and other biomaterials to improve patient outcomes.
Company News
Anika Therapeutics announced clinical trial results for Hyalofast that did not meet pre-specified endpoints, causing a 27.42% stock price drop and triggering a potential legal investigation.
In the latest quarter, 4 analysts provided ratings for Anika Therapeutics (NASDAQ:ANIK), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bea...
Philips' (PHG) first-quarter results benefit from strong momentum across the Diagnosis & Treatment and Personal Health businesses. However, softness in the Connected Care business is a concern.
ANIK earnings call for the period ending September 30, 2021.
